Patents Assigned to Precision Immunotherapy, Inc.
  • FLT3 DIRECTED CAR CELLS FOR IMMUNOTHERAPY
    Publication number: 20180118838
    Abstract: CAR cells targeting FLT3 relevant antigens are described as a new method of cancer treatment. It is proposed that FLT3 CAR cells are safe and effective in patients and can be used to treat human tumors and cancer.
    Type: Application
    Filed: November 13, 2017
    Publication date: May 3, 2018
    Applicant: Precision Immunotherapy, Inc.
    Inventors: Jianhua Yu, Michael Caligiuri, Steven Devine